What is the normal quantitative serum alpha‑1 antitrypsin (A1AT) level, how should the result be interpreted, and what are the recommended next steps for abnormal values?

Normal Alpha-1 Antitrypsin Levels and Interpretation

Normal serum alpha-1 antitrypsin (A1AT) levels are ≥23 µmol/L (≥1.2 g/L or ≥120 mg/dL), and any value below this threshold warrants DNA sequencing of the SERPINA1 gene to definitively diagnose A1AT deficiency. 1

Understanding Normal Reference Ranges

The normal A1AT level varies by phenotype:

• PI*MM (normal): 150-350 mg/dL or 20-48 µmol/L 2
• PI*MZ (heterozygote): 90-210 mg/dL or 17-33 µmol/L 2
• PI*SS: 100-200 mg/dL or 15-33 µmol/L 2
• PI*SZ: 75-120 mg/dL or 8-16 µmol/L 2
• PI*ZZ (severe deficiency): 20-45 mg/dL or 2.5-7 µmol/L 2

Critical caveat: Commercial assays using radial immunodiffusion overestimate A1AT concentrations by 35-40% compared to purified standards 2. This is why different units exist—mg/dL for commercial standards versus µmol/L for purified standards.

Interpretation Algorithm

Step 1: Initial Serum A1AT Measurement

If A1AT ≥23 µmol/L (≥1.2 g/L): Severe A1AT deficiency is ruled out in most cases, and no further testing is needed in moderate suspicion scenarios 1

If A1AT <23 µmol/L (<1.2 g/L): Proceed immediately to SERPINA1 DNA sequencing 1

Step 2: Account for Inflammation

A1AT is an acute-phase reactant—levels rise during inflammation, infection, or injury 2, 3. This creates a major diagnostic pitfall:

• Inflammation can mask true deficiency by elevating A1AT levels into the "normal" range 3
• Approximately 25% of PI*MZ individuals show signs of inflammation that artificially elevate their A1AT 3
• Some authors suggest levels as high as 1.4 g/L may occur in deficient patients during acute inflammation 1

Action: Check C-reactive protein (CRP) simultaneously with A1AT 4, 3. If CRP is elevated (≥5 mg/L), the A1AT result may be falsely reassuring.

Step 3: High Suspicion Scenarios—Bypass Serum Testing

Proceed directly to DNA sequencing if any of the following are present, regardless of A1AT level 1:

• Early-onset COPD (before age 40)
• Minimal tobacco exposure (<10 pack-years) with emphysema
• Panlobular emphysema pattern on CT
• Family history of COPD or known A1AT deficiency
• First-degree relatives of individuals with A1AT deficiency

Recommended Next Steps for Abnormal Values

If A1AT <23 µmol/L (<1.2 g/L):

1. Order SERPINA1 DNA sequencing (exons 2-5)—this is the gold standard 1

   • DNA sequencing identifies all 300+ genetic variants, not just common ones
   • Genetic results are invariable, unlike fluctuating protein levels
   • Essential for detecting rare dysfunctional variants with normal quantitative levels (e.g., PI*F)

2. Collect both tubes simultaneously for efficiency 1:

   • Red cap (serum) for A1AT level
   • Lavender cap (buffy coat) for DNA sequencing

If Severe Deficiency Confirmed (A1AT <11 µmol/L or <0.57 g/L):

Augmentation therapy eligibility criteria 1:

• Documented severe A1AT deficiency with serum level <11 µmol/L (0.57 g/L)
• Clinical evidence of COPD with emphysema on CT
• FEV₁ <80% predicted
• Non-smoker for ≥6 months
• No prior lung transplant

If Intermediate Deficiency (e.g., PIMZ, PISZ):

DNA sequencing is essential because A1AT levels overlap between genotypes, making phenotype determination impossible by quantitative testing alone 1. Precise genotype knowledge triggers:

• Intensive smoking cessation counseling
• Occupational exposure avoidance
• Family cascade screening
• Risk stratification for COPD development

Common Pitfalls to Avoid

1. Relying solely on A1AT levels without genetic confirmation: Levels fluctuate with inflammation, making classification unreliable in intermediate ranges 1

2. Using outdated "protective threshold" of 11 µmol/L for screening: This threshold (historically 80 mg/dL by radial immunodiffusion, 50 mg/dL by nephelometry) is for treatment eligibility, not screening 2. The screening threshold is 23 µmol/L (1.2 g/L) 1

3. Testing during acute illness: Inflammation artificially elevates A1AT, potentially missing deficiency 3. Always check CRP or retest when stable.

4. Assuming normal levels exclude all deficiency: Rare dysfunctional variants (e.g., PI*F) have normal quantitative levels but impaired function 1. High clinical suspicion mandates DNA sequencing regardless of level.

5. Using phenotyping instead of genotyping: Phenotyping (isoelectric focusing) requires specialized expertise and only identifies common variants 2. DNA sequencing is more comprehensive and increasingly accessible 1

Unit Conversion Reference

Due to different standards and methods, be aware of unit variations 2, 1:

• Commercial standard: mg/dL (overestimates by 35-40%)
• Purified standard: µmol/L or µM
• International units: g/L

Key conversion: 23 µmol/L = 1.2 g/L = 120 mg/dL (nephelometry) = 80 mg/dL (purified standard)